Clinical Trial Patient Activation (CTPA)
GRYT’s “CTPA” is a proven solution to drive recruitment and support representation on high-priority clinical trials.
We developed our innovative approach through successful collaboration with sponsors to:
Position clinical trials with clearly articulated differentiators
Increase awarenesss with physicians and patients based on targeted geo and demographic factors – particularly for underrepresented patients
Utilize a scalable approach with real-time engagement and conversion analytics
Demonstrate results and optimize efforts with bi-weekly reporting
Over the past decade, Gryt’s innovative CTPA solution has successfully enrolled high-priority trials and helped our clients achieve FDA goals.
After working with Lilly COI and leading LIVESTRONG’S Clinical Trial Matching Service, David Craig co-founded Gryt Health in 2016.
Gryt’s first client was Ignyta, where we helped successfully enroll its NTRK trial
Gryt was awarded the Participant Engagement Award at SCOPE in 2019 and 2021
Engagement by Site Location
Each pin represents a person searching on Google, saw the campaign, utilized Gryt’s engagement platform and then took action for enrollment.
Outcomes Achieved
Facilitated patient-focused trial education, boosting awareness and screening
Engaged underrepresented patients by race, ethnicity & rural settings
Delivered actionable insights/ analytics for overall and site-specific recruitment
Increased patient diversity in screening
KPI’s are utilized to complete the read-out for FDA Diversity Action Plan